Chromatographic Estimation of a Novel Triple-Therapy Combination Targeting Helicobacter Pylori Eradication in Different Matrices

References

• Veldhuyzen Van Zanten SJO , ShermanPM. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ150(2), 177–185 (1994).
   PubMed Web of Science ®Google Scholar
• Balamtekin N , ArtukC, ArslanM, GülşenM. The effect of Helicobacter pylori on the presentation and clinical course of coronavirus disease 2019 infection. J. Pediatr. Gastroenterol. Nutr.72, 511–513 (2021).
   PubMed Web of Science ®Google Scholar
• Uno Y . Why does SARS-CoV-2 invade the gastrointestinal epithelium. Gastroenterology159, 1622–1623 (2020).
   PubMed Web of Science ®Google Scholar
• Sonkar C , KashyapD, VarshneyN, BaralB, JhaHC. Impact of gastrointestinal symptoms in COVID-19: a molecular approach. SN Compr. Clin. Med.2(12), 2658–2669 (2020).
   PubMedGoogle Scholar
• Börsch G , MaiU, MüllerKM. Monotherapy or polychemotherapy in the treatment of Campylobacter pylori-related gastroduodenal disease. Scand. J. Gastroenterol.23(S142), 101–106 (1988).
   Google Scholar
• Harris Aw , PryceDi, GabeSmet al. Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection. Aliment. Pharmacol. Ther.10(6), 1005–1008 (1996).
   PubMed Web of Science ®Google Scholar
• The British Pharmacopoeia. Her Majesty's Stationary Office.London, UK (2013).
   Google Scholar
• Edwards DI . Nitroimidazole drugs-action and resistance mechanisms of action. J. Antimicrob. Chemother.31(1), 9–20 (1993).
   PubMed Web of Science ®Google Scholar
• Li W , JiaH, ZhaoK. Determination of clarithromycin in rat plasma by HPLC-UV method with pre-column derivatization. Talanta71(1), 385–390 (2007).
   PubMed Web of Science ®Google Scholar
• Peters DH , ClissoldSP. Clarithromycin: a review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Drugs44(1), 117–164 (1992).
   PubMed Web of Science ®Google Scholar
• Tsiakos K , TsakirisA, TsibrisGet al. Oral clarithromycin in COVID-19 of moderate severity: the ACHIEVE open-label trial using concurrent matched comparators. medRxivhttps://www.medrxiv.org/content/10.1101/2020.12.22.20248753v1 (2020).
   Google Scholar
• Martingano D , NguyenA, NkeihC, SinghS, MitrofanovaA. Clarithromycin use for adjunct surgical prophylaxis before non-elective cesarean deliveries to adapt to azithromycin shortages in COVID-19 pandemic. PLoS One.15(12), e0244266 (2020).
   PubMed Web of Science ®Google Scholar
• Wisher D . Martindale: the complete drug reference. 37th ed. J. Med. Libr. Assoc.100(1), 75–76 (2012).
   Web of Science ®Google Scholar
• Gremse DA . Lansoprazole: pharmacokinetics pharmacodynamics and clinical uses. Expert Opin. Pharmacother.2(10), 1663–1670 (2001).
   PubMedGoogle Scholar
• Bazzoli F , PozzatoP, ZagariMet al. Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta analysis . Helicobacter 3(3), 195–201 (1998).
   PubMed Web of Science ®Google Scholar
• Celia C , MarzioL Di, LocatelliM, RamundoP, D'AmbrosioF, TartagliaA. Current trends in simultaneous determination of co-administered drugs. Sep. 2020, Vol. 7, Page 29.7(2), 29 (2020).
   Google Scholar
• Abdelwahab NS , EdreesFH, alsaadiMT, AminNH, SaadAS. Therapeutic drug monitoring of two co-administered drugs through development of two ecological chromatographic methods: in vivo application. Microchem. J.156(March), 104935 (2020).
   Google Scholar
• Kang JS , LeeMH. Overview of therapeutic drug monitoring. Korean J. Intern. Med.24(1), 1–10 (2009).
   PubMedGoogle Scholar
• Darwish KM , SalamaI, MostafaS, El-SadekM. RP-HPLC/pre-column derivatization for analysis of omeprazole, tinidazole, doxycycline and clarithromycin. J. Chromatogr. Sci.51(6), 566–576 (2013).
   PubMed Web of Science ®Google Scholar
• Salem H , RiadSM, RezkMR, AhmedK.Simultaneous determination of omeprazole, tinidazole and clarithromycin in bulk powder and Helicure® tablets by HPLC. J. Chromatogr. Sep. Tech.05(2), 1–5 (2014).
   Google Scholar
• Ahmed S , AtiaNN. Simultaneous determination of triple therapy for Helicobacter pylori in human plasma by reversed phase chromatography with online wavelength switching. Spectrochim. Acta – Part A Mol. Biomol. Spectrosc.136(PC), 1380–1387 (2015).
   PubMedGoogle Scholar
• Smerikarova M , BozhanovS, MaslarskaV. Development and validation of an RP-HPLC method to quantify amoxicillin, tinidazole, esomeprazole and lansoprazole in a mixture. Indian J Pharm Sci81(6), 1122–1127 (2019).
   Web of Science ®Google Scholar
• US FDA . Guidance for Industry. Dissolution Testing of Immediate Release Solid Oral Dosage Forms. US department of health and human services, center for drug evaluation and research (1997). https://www.fda.gov/media/70936/download
   Google Scholar
• US FDA . Guidance for Industry. Bioanalytical method validation. US Department of Health and Human Services, Center for Drug Evaluation and Research and Center for Veterinary Medicine (2018). https://www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf
   Google Scholar
• Snyder L , DolanJ. High-Performance Gradient Elution: The Practical Application of the Linear-Solvent-Strength Model.Wiley, NY, USA, 163–168 (2007).
   Google Scholar
• ICH, International Conference on Harmonization of technical requirements for registration of pharmaceutical for human use. ICH harmonised tripartite guideline, Validation of Analytical Procedures: Text and Methodology Q2 (R1) (2005).
   Google Scholar
• Mattila J , MannistoPT, MantylaR, NykänenS, LamminsivuU. Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route. Antimicrob. Agents Chemother.23(5), 721–725 (1983).
   PubMed Web of Science ®Google Scholar